Monitoring patients for possible QTC prolongation with psychotropic use can be difficult--even more so in children or adolescents. What screening and treatment techniques should be used for maximum therapeutic benefit with minimum cardiac risk?
Michael J. Labellarte, MD
Advertisement
Articles by Michael J. Labellarte, MD
Advertisement
Latest Updated Articles
- Assessing Risk of QTC Prolongation
Published: May 1st 2004 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Patent Issued for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder
2
When Symptoms Are Not Necessarily Signs of Illness: Rethinking Synchronicity in Psychiatry
3
Study Finds Semaglutide Is Associated With Improved Cognitive Function in Individuals With Psychiatric Disorders
4
International Stuttering Awareness Day: Why Psychiatrists Should Pay Attention
5
